MMP2 and hepatocellular carcinoma: Apart from the anti-CD 147 antibody strategy, researchers have demonstrated that small molecule (AC-73) inhibitors of CD147 dimerization can suppress MMP-2 production in hepatocellular carcinoma via the CD147-ERK-STAT 3-MMP-2 signaling pathway (104).